Vascular Biogenics (VBLT) Reports Q2 Loss, Misses Revenue Estimates

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Vascular Biogenics Ltd. (VBLT): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research
Zacks Investment Research – All Commentary Articles

Pin It